SMO ClinPlus Co. Ltd. (301257) — Cash Flow Reinvestment Rate

Latest as of December 2025: 2.87x

SMO ClinPlus Co. Ltd. (301257) has a Cash Flow Reinvestment Rate of 2.87x as of December 2025, reinvesting CN¥102.61 Million (capex CN¥7.83 Million plus investments CN¥94.78 Million) from operating cash flow of CN¥35.69 Million. Explore SMO ClinPlus Co. Ltd. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.87x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥102.61 Million
Capex + Investments

Operating Cash Flow

CN¥35.69 Million
CNY

Capital Expenditures

CN¥7.83 Million
CNY

SMO ClinPlus Co. Ltd. Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for SMO ClinPlus Co. Ltd. across 6 annual periods. Also explore total assets of SMO ClinPlus Co. Ltd. for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for SMO ClinPlus Co. Ltd. (2019–2025)

Year-by-year capital reinvestment analysis for SMO ClinPlus Co. Ltd.. For live market cap and broader valuation context, see SMO ClinPlus Co. Ltd. market cap and net worth.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.87x CN¥102.61 Million CN¥35.69 Million CN¥7.83 Million ▲ +12.0%
2023 2.57x CN¥294.70 Million CN¥114.85 Million CN¥10.25 Million ▼ -30.9%
2022 3.71x CN¥150.07 Million CN¥40.44 Million CN¥7.95 Million ▲ +1653.2%
2021 0.21x CN¥8.79 Million CN¥41.52 Million CN¥4.40 Million ▼ -41.7%
2020 0.36x CN¥8.15 Million CN¥22.45 Million CN¥4.08 Million ▼ -1.7%
2019 0.37x CN¥16.82 Million CN¥45.53 Million CN¥4.91 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow